Anavex Life Sciences Corp (AVXL)

[boi568]

I think there are large gaps between test completion and full readout because Anavex is both conducting clinical trials and wide-ranging, groundbreaking scientific research.

Anavex is the first to seriously explore the Sigma 1 receptor and its effect on CNS disease at large. This is a much more ambitious undertaking than just going through one monoclonal antibody after another, like Edison searching for the best light bulb filament. It goes quicker if you take the time to get it right the first time. And the payoff, as Missling has suggested over the years, will be worth the wait.